AOD-9604 3.6mg
Lipolytic HGH fragment — targeted fat loss without diabetogenic effects
BioBlend Pharma Grade3ml vialThe Fat-Burning Fragment
AOD-9604 3.6mg
Lipolytic HGH fragment — targeted fat loss without diabetogenic effects
Contact for pricing
Administration
Injectable
First Results
2–4 weeks
Cycle Length
12-week cycles
Clinical Uses
- Stubborn body fat reduction
- Visceral and subcutaneous fat loss
- Metabolic syndrome support
- Weight-loss plateau breaking
- Post-weight-loss composition refinement
Key Benefits
- Directly stimulates fat cell breakdown
- Does NOT raise blood sugar (unlike hGH)
- Does NOT suppress natural GH production
- Safe for long-term use
- No water retention or insulin resistance
How It Works — Mechanism of Action
AOD-9604 binds beta-3 adrenergic receptors on adipocytes, raising cAMP and activating hormone-sensitive lipase to break down triglycerides while inhibiting lipogenesis.
Your AOD-9604 3.6mg protocol, wherever you are
A pre-filled, easy-to-carry pen for self-administration at home, the gym or the office. Dispensed safely after physician approval and delivered cold-chain to you.
Dosage Protocol
300–500 mcg subcutaneous injection daily, morning fasted. Cycle 3 months on, 1 month off.
When to Expect Results
Weeks 2–4: reduced waist circumference. Months 2–3: visible fat loss. Month 3: compositional remodelling.
Side Effects
Generally well tolerated. Rare: mild injection-site redness. Contact your physician for any unusual symptom.
Contraindications
Active cancer, pregnancy, hypersensitivity to peptide components. Always review with your physician.
Best Stacked With
Consult your physician for synergistic stacking options matched to your goal.
Understanding Your Body’s Language
Ready to start your AOD-9604 3.6mg protocol?
All peptide protocols require a physician consultation and blood work. Our licensed UAE team will craft a personalised plan for you.
Book a consultation